Literature DB >> 21864819

Usefulness of serum bilirubin and cardiorespiratory fitness as predictors of mortality in men.

Rahma Ajja1, Duck-Chul Lee, Xuemei Sui, Timothy S Church, N Blair Steven.   

Abstract

Elevated serum bilirubin has been suggested to reduce the risk for mortality. Cardiorespiratory fitness (CRF) has also been reported to have inverse association with all-cause and cardiovascular disease (CVD) mortality. The association between serum bilirubin, all-cause and CVD mortality, and the effect of CRF on the observed association was investigated. A total of 1,279 men aged 30 to 82 years underwent baseline medical examinations from 1974 to 1997 at the Cooper Clinic in Dallas, Texas. During an average of 17 years of follow-up, 698 men died, with 253 deaths due to CVD (36%). Men in the highest bilirubin quartiles had significantly lower risk for all-cause mortality compared to men in the lowest quartiles (p for trend = 0.0043), after adjusting for age and examination year. This inverse association remained significant after further adjustment for known confounders (p for trend = 0.0018). Additional adjustment for treadmill time attenuated the association (p for trend = 0.0090). Similar patterns of association were observed between serum bilirubin quartiles and CVD mortality. CRF was inversely associated with all-cause mortality (p for trend <0.0001) after adjusting for age and examination year. This inverse association also was observed after further adjusting for known confounders (p for trend = 0.0004). After additional adjustment for serum bilirubin, the association between CRF and all-cause mortality remained significant (p for trend = 0.0012). All-cause mortality and CVD mortality were significantly lower in men in the moderate- to high-fitness quartiles in the low- and high-bilirubin groups. In conclusion, serum bilirubin level and CRF level were strongly and independently associated with all-cause and CVD mortality.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864819      PMCID: PMC3206143          DOI: 10.1016/j.amjcard.2011.06.067

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

1.  Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study.

Authors:  L Djoussé; D Levy; L A Cupples; J C Evans; R B D'Agostino; R C Ellison
Journal:  Am J Cardiol       Date:  2001-05-15       Impact factor: 2.778

Review 2.  Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle.

Authors:  Thomas W Sedlak; Solomon H Snyder
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124

3.  Serum bilirubin and 10-year mortality risk in a Belgian population.

Authors:  E H Temme; J Zhang; E G Schouten; H Kesteloot
Journal:  Cancer Causes Control       Date:  2001-12       Impact factor: 2.506

4.  A comparative analysis of four protocols for maximal treadmill stress testing.

Authors:  M L Pollock; R L Bohannon; K H Cooper; J J Ayres; A Ward; S R White; A C Linnerud
Journal:  Am Heart J       Date:  1976-07       Impact factor: 4.749

5.  Bilirubin is an antioxidant of possible physiological importance.

Authors:  R Stocker; Y Yamamoto; A F McDonagh; A N Glazer; B N Ames
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

6.  Cardiovascular fitness as a predictor of mortality in men.

Authors:  J A Laukkanen; T A Lakka; R Rauramaa; R Kuhanen; J M Venäläinen; R Salonen; J T Salonen
Journal:  Arch Intern Med       Date:  2001-03-26

7.  Exercise-induced oxidative stress in older adults as a function of habitual activity level.

Authors:  Erwin P Meijer; Annelies H C Goris; Joost L J van Dongen; Aalt Bast; Klaas R Westerterp
Journal:  J Am Geriatr Soc       Date:  2002-02       Impact factor: 5.562

8.  Maximal exercise test as a predictor of risk for mortality from coronary heart disease in asymptomatic men.

Authors:  L W Gibbons; T L Mitchell; M Wei; S N Blair; K H Cooper
Journal:  Am J Cardiol       Date:  2000-07-01       Impact factor: 2.778

9.  Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women.

Authors:  Heejin Kimm; Ji Eun Yun; Jaeseong Jo; Sun Ha Jee
Journal:  Stroke       Date:  2009-08-27       Impact factor: 7.914

10.  Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men.

Authors:  Peter T Katzmarzyk; Timothy S Church; Steven N Blair
Journal:  Arch Intern Med       Date:  2004-05-24
View more
  12 in total

1.  Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study.

Authors:  Amir A Mahabadi; Nils Lehmann; Stefan Möhlenkamp; Hagen Kälsch; Marcus Bauer; Rainer Schulz; Susanne Moebus; Karl-Heinz Jöckel; Raimund Erbel; Gerd Heusch
Journal:  Clin Res Cardiol       Date:  2014-03-15       Impact factor: 5.460

2.  Association of serum total bilirubin levels with the severity, extent and subtypes of coronary atherosclerotic plaques detected by coronary CT angiography.

Authors:  Uğur Canpolat; Kudret Aytemir; Hikmet Yorgun; Tuncay Hazırolan; Ergün Barış Kaya; Levent Şahiner; Hamza Sunman; Lale Tokgözoğlu; Giray Kabakcı; Ali Oto
Journal:  Int J Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 2.357

3.  Dual Effects of Bilirubin on the Proliferation of Rat Renal NRK52E Cells and ITS Association with Gap Junctions.

Authors:  Yanling Wang; Qiongfang Zhu; Chenfang Luo; Ailan Zhang; Ziqing Hei; Guangjie Su; Zhengyuan Xia; Michael G Irwin
Journal:  Dose Response       Date:  2012-07-30       Impact factor: 2.658

4.  Low-normal free thyroxine confers decreased serum bilirubin in type 2 diabetes mellitus.

Authors:  Petronella E Deetman; Arjan J Kwakernaak; Stephan J L Bakker; Robin P F Dullaart
Journal:  Thyroid       Date:  2013-09-04       Impact factor: 6.568

5.  Bile pigments in pulmonary and vascular disease.

Authors:  Stefan W Ryter
Journal:  Front Pharmacol       Date:  2012-03-08       Impact factor: 5.810

Review 6.  Low-normal thyroid function and novel cardiometabolic biomarkers.

Authors:  Lynnda J N van Tienhoven-Wind; Robin P F Dullaart
Journal:  Nutrients       Date:  2015-02-16       Impact factor: 5.717

7.  High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome.

Authors:  Petronella E Deetman; Stephan J L Bakker; Robin P F Dullaart
Journal:  Cardiovasc Diabetol       Date:  2013-11-09       Impact factor: 9.951

8.  The relationship of the anti-oxidant bilirubin with free thyroxine is modified by insulin resistance in euthyroid subjects.

Authors:  Petronella E Deetman; Stephan J L Bakker; Arjan J Kwakernaak; Gerjan Navis; Robin P F Dullaart
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

9.  The relationship between total bilirubin levels and total mortality in older adults: the United States National Health and Nutrition Examination Survey (NHANES) 1999-2004.

Authors:  Kwok-Leung Ong; Matthew A Allison; Bernard M Y Cheung; Ben J Wu; Philip J Barter; Kerry-Anne Rye
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

10.  Baseline Serum Bilirubin and Risk of First Stroke in Hypertensive Patients.

Authors:  Jiancheng Wang; Xianglin Zhang; Zhuxian Zhang; Yuanyuan Zhang; Jingping Zhang; Huan Li; Youbao Li; Binyan Wang; Jing Nie; Min Liang; Guobao Wang; Yefeng Cai; Jianping Li; Yan Zhang; Yong Huo; Yimin Cui; Xiping Xu; Xianhui Qin
Journal:  J Am Heart Assoc       Date:  2020-06-03       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.